FASLODEX is indicated for the treament of hormone receptor-positive metastatic breast
cancer in postmenopausal women with disease progression following antiestrogen therapy.
*Estrogen receptor |
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.